Clinical trials - Press Releases

Date	Title	Company
09-Dec-2019	ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available	ViiV Healthcare
09-Dec-2019	Takeda and Enzyre to develop diagnostic device allowing hemophilia patients to determine their coagulation status at home	Takeda Pharmaceutical Company Limited
09-Dec-2019	PHARMASEAL Scoops its First Industry Award as Best Start-Up of the Year At Medilink East Midlands Business Awards 2019	PHARMASEAL
09-Dec-2019	PureTech Affiliate Vedanta Biosciences Awarded $5.8 Million CARB-X Grant to Accelerate Development of VE707 for Multi-Drug Resistant Infections	PureTech Health plc
09-Dec-2019	HUMMINGBIRD BIOSCIENCE RAISES US$19 MILLION IN SERIES B FINANCING	Hummingbird Bioscience
09-Dec-2019	PHASTAR Gains 2020 ‘Best Companies’ Accreditation for Employee Engagement	PHASTAR
09-Dec-2019	Orgenesis launches Point of Care cell and gene therapy centers within HYGEIA Group’s Greek hospital network	HYGEIA Group
09-Dec-2019	Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis	Galderma
09-Dec-2019	Gelesis Secures Over $84 Million in New Capital to Support Commercialization of PLENITY™	Gelesis
09-Dec-2019	Nouscom – First Patient Dosed in a Phase 1 Trial with NOUS-209, an ‘off-the-shelf’ Neoantigen Cancer Vaccine, in MSI-High Solid Tumors	Nouscom
09-Dec-2019	HVIVO (“HVIVO”) to merge with OPEN ORPHAN PLC (“OPEN ORPHAN”)	The Boards of Open Orphan and hVIVO
09-Dec-2019	Moberg Pharma meets primary endpoint for MOB-015 in a Phase 3 study for the treatment of onychomycosis	Moberg Pharma AB
06-Dec-2019	Key Objectives of The Medical Device and In-Vitro Diagnostic Regulations	PharmaLex
06-Dec-2019	Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen	Genmab
06-Dec-2019	First Clinical Study Evaluating Combined tDCS And Behaviour Therapy Could Point To A New Treatment For Depression	Flow Neuroscience
05-Dec-2019	CluePoints’ Risk-Based Quality Management Software Wins Best Technological Development in Clinical Trials at SCRIP Awards 2019	CluePoints
05-Dec-2019	Inceptua appoints new President North America	Inceptua
05-Dec-2019	Lessons from EU Medical Device Regulation compliance preparations	Kallik
04-Dec-2019	New global survey shows misperceptions about lung cancer among the general public	Lung Ambition Alliance
04-Dec-2019	ASLAN PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES	ASLAN Pharmaceuticals